CDK4/6 Inhibitor Clinical Trials
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Breast Cancer RElapsed in Patients Treated With Adjuvant CDK4/6 Inhibitors:
Adjuvant TherapyCDK4/6 Inhibitor
European Institute of Oncology750 enrolled18 locationsNCT07180693
Recruiting
Not Applicable
Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer
CDK4/6 InhibitorChemotherapeutic ToxicityTrastuzumab+5 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences148 enrolled1 locationNCT06197581